| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 253,074 | 277,411 | 349,695 | 371,388 | | Cost of Revenue | 238,120 | 246,608 | 291,677 | 333,375 | | | Gross Profit | 14,954 | 30,803 | 58,018 | 38,013 | | | Operating Expenses | | Research Development | 14,098 | 15,074 | 16,696 | 20,732 | | Selling General and Administrative | 59,016 | 51,288 | 56,442 | 55,664 | | Non Recurring | (8,585) | 4,956 | 54,470 | 68,497 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (49,575) | (40,515) | (69,590) | (106,880) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (425) | (2,919) | (5,677) | 5,721 | | Earnings Before Interest And Taxes | (83,005) | (43,434) | (75,267) | (103,060) | | Interest Expense | (19,123) | 13,405 | 5,718 | 6,344 | | Income Before Tax | (63,882) | (56,839) | (80,985) | (109,404) | | Income Tax Expense | 6,024 | 61,558 | (8,413) | (18,795) | | Minority Interest | (894) | (3,429) | (5,834) | (1,901) | | | | Net Income From Continuing Ops | (81,505) | (121,826) | (78,406) | (90,609) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (70,800) | (121,826) | (78,406) | (90,609) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($70,800) | ($121,826) | ($78,406) | ($90,609) |
|
1.00% Nasdaq 
0.07 (0.73%) 
Income Statement
